Author:
M. Majali BARC Isotope Division Bombay (India)

Search for other papers by M. Majali in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

186Re is considered as Therapy Isotope and can be used in radioimmunotherapy. The radiation characteristics of this isotope are ideal for therapy. Generally metallic radionuclides are labeled to antibodies through bifunctional chelating agents, such as DTPA (diethylenetetraaminepentaacetic acid). A study has been carried out on the complexation of DTPA with186Re using low specific activity186Re. This was carried out to evaluate various parameters which are involved in the complex formation including methods of processing of raw material186Re. Stannous chloride was used as the reducing agent for the reduction of rhenium. Different labeling conditions such as pH, time, temperature and concentration of reducing agent were all studied for complex formation. The complex was characterized by paper electrophoresis, paper chromatography and gel column chromatography.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)